Business Wire

SoftServe Launches Generative AI Lab

29.8.2023 15:03:00 CEST | Business Wire | Press Release

Share

SoftServe, a premier IT consulting and digital services provider, today announced the launch of its Generative AI Lab to help enterprises achieve tangible business results with the successful implementation of Generative AI solutions. The new lab expands SoftServe’s AI/ML capabilities with advanced generative model research and development in multimodal AI applications, as well as a dedicated team of experts to harness and accelerate the transformative power of Generative AI from discovery to real-world adoption.

"Unlike other areas with more developed and mature best practices, Generative AI stands out with its novelty and emergent properties unveiling not just technological innovations, but also groundbreaking use cases that may redefine business strategies,” said Alex Chubay, SoftServe’s Chief Technology Officer. “The pace of innovation here is staggering, often overwhelming businesses with new advancements released weekly. This is where the Generative AI Lab shines. It's not just a hub for rapid experimentation, value discovery, and solution engineering with the latest techniques and technologies. It's a conduit for channeling this explosive innovation directly to our clients."

SoftServe’s Generative AI Lab will support R&D efforts in several pivotal areas, including model fine-tuning and domain adaptation, multimodal Generative AI, cost-performance optimization, operational management (LLMOps), and more. Fusing multiple emerging technologies and approaches in these focus areas will produce pioneering use cases across industries. With these research priorities meticulously aligned with SoftServe’s client needs and strategies, the expertise and assets generated within the lab will find their organic way into real-world business scenarios, ensuring practical and impactful adoption.

“To move forward, we must be strategic about implementation,” said Iurii Milovanov, SoftServe’s AVP of AI & Data Science. “This is where a pragmatic approach becomes critical to proving these once-hypothetical possibilities can make real impacts across various business functions and industries.”

SoftServe’s three Generative AI offerings include:

  1. AI Discovery – The initial discovery phase guides clients through the intricacies of the Generative AI landscape, revealing and validating its potential impact and feasibility within their organizations.
  2. AI Launchpad – The launchpad program enables rapid experimentation and evidence-based exploration of new use cases through a Generative AI sandbox, which enables users to scout, validate, and test deployment.
  3. AI Adoption – The final offering helps clients rapidly scale their Generative AI solutions across the whole enterprise with initiative road mapping, AI governance, technology and data strategies, as well as full AI solution development and adoption in engineering teams.

SoftServe’s Generative AI Lab uses tools and technology platforms in partnership with AWS, Google Cloud, Microsoft Azure, and NVIDIA. The results-oriented practice applies successful use cases and an assessment framework established to make Generative AI a cross-industry, business reality.

Visit this webpage to learn more about SoftServe's Generative AI solutions and capabilities.

ABOUT SOFTSERVE

SoftServe is a premier IT consulting and digital services provider. We expand the horizon of new technologies to solve today's complex business challenges and achieve meaningful outcomes for our clients. Our boundless curiosity drives us to explore and reimagine the art of the possible. Clients confidently rely on SoftServe to architect and execute mature and innovative capabilities, such as digital engineering, data and analytics, cloud, and AI/ML.

Our global reputation is gained from more than 30 years of experience delivering superior digital solutions at exceptional speed by top-tier engineering talent to enterprise industries, including high tech, financial services, healthcare, life sciences, retail, energy, and manufacturing. Visit our website, blog, LinkedIn, Facebook, and Twitter pages for more information.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Kayla Cash
Global Public Relations Manager
SoftServe, Inc.
kcash@softserveinc.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease1.5.2026 23:28:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meeting the evolving needs of patients with myeloproliferative neoplasms (MPNs) and GVHD,” said Bill Meury, Chief Executive Officer, Incyte. “Jakafi XR offers appropriate patients and physicians a once-daily option, expanding choice without changing the well-

Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 18:08:00 CEST | Press Release

A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines were switched off and everyday life took center stage. The night also celebrated the start of the new partnership between Barilla and the Visa Cash App Racing Bulls (VCARB) Formula 1® Team, a meeting of

TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 12:07:00 CEST | Press Release

Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the

Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 01:17:00 CEST | Press Release

Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan

Grindr Nominates Three New Directors to Its Board of Directors30.4.2026 23:16:00 CEST | Press Release

Grindr Inc. (NYSE: GRND), the Global Gayborhood in Your Pocket™, today announced the nomination of Rob Solomon, Lisa Gersh, and Fadi Hanna to stand for election to its Board of Directors at the Annual Meeting of Shareholders on June 2, 2026. Rob Solomon is a deeply seasoned technology CEO and operator in consumer internet and marketplaces. He has held CEO and COO roles at scaled platforms including GoFundMe, Groupon, and Kayak-predecessor SideStep, and is currently CEO of leading electric aviation company H55. Lisa Gersh is a CEO and long-tenured public company director with deep experience across consumer brands, media, and commerce. She has served on the Hasbro (NASDAQ: HAS) board since 2010 and has led businesses including Oxygen Media, GOOP, and Alexander Wang. Fadi Hanna is Chief Risk Officer at Bloomberg L.P., overseeing enterprise risk across the organization. He previously worked at J.P. Morgan and has served on the board of Immigration Equality. “Over the last few years, we bu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye